Be Part of the Generation that Cures Alzheimer’s
Clinical trials are an essential part of Alzheimer’s disease research, and volunteers who participate in clinical trials help make advances in prevention and new treatments possible. Several NEW clinical trials are underway in Tennessee. Now you have the opportunity to take part in research that could help prevent and cure Alzheimer’s.
VRG/NOCCR in Knoxville is one of the Novartis research sites across the world that is part of the Generation Program. They are looking for individuals who are 60 to 75 years of age and currently show no signs of cognitive impairment. Do something unforgettable today and find out if you — or someone you love — could be a part of the Generation that prevents and cures Alzheimer’s!
“The previous generation is known as the greatest generation,” says Janice Wade-Whitehead, President and CEO of Alzheimer’s Tennessee. “But the baby boomers could be known as the generation that makes the greatest impact to cure Alzheimer’s, one of the most dreaded diseases of our time.”
VRG/NOCCR is housed in the UT Medical Center. Call (865)305-DRUG (3784).
The Generation Program across Tennessee
Memphis Clinical Neuroscience Solutions (901) 843-1045.
Nashville The Center for Cognitive Medicine (615) 936-0231.
National Institutes of Health Recommends New Alzheimer's Research Strategy
NIH calls for transformative research agenda, collaboration and big data to enable precision medicine.
Veggies to Help "BEET" Alzheimer's
Vegetable compound could have a key role in ‘beeting’ Alzheimer’s disease
Potential Alzheimer's Blood Test Could Speed Diagnosis
Screening for toxic beta-amyloid proteins could also aid Alzheimer's disease research.
Brain Cell Loss May Be Very Limited in Alzheimer's Disease
New research challenges current scientific consensus on Alzheimer's disease pathology
Diabetes Research Leads to Possible Alzheimer's Treatment
A drug developed for diabetes could be used to treat Alzheimer's after scientists found it "significantly reversed memory loss" in mice through a triple method of action.
Neuroscientist Optimistic about Future Alzheimer's Treatments
Neuroscientist Joseph Jebelli predicts stem cell research will lead to better therapies in coming decade.
Brain Inflammation Attracts Alzheimer's Plaque Forming Protein
Results in mice study suggest a possible approach for stopping amyloid-beta accumulation.
Movement of Amyloid-beta Could Suggest New Ways to Treat Alzheimer's
Alzheimer’s protein can travel from blood to build up in the brain.
Alzheimer's brain damage halved with gene-targeting compound
New research shows a molecule used against the APOE gene in mice could reduce Alzheimer's related brain damage by half.
Hormone therapy and Alzheimer's disease
Introducing hormone treatment for women in early stages of menopause might help decrease their risk of dementia or Alzheimer’s disease.